Peer-reviewed articles

Zhang M, Kelly C, McCarthy T, et al. Examining the COVID-19 impact on cancer surgery in Ireland using three national data sources. Glob Epidemiol. 2024;8:100159. doi:10.1016/j.gloepi.2024.100159

White P, Brennan A, McDevitt J, et al. Screen-detected breast cancer and cancer stage by area-level deprivation: a descriptive analysis using data from the National Cancer Registry Ireland. Eur J Public Health. Published online December 13, 2024:ckae204. doi:10.1093/eurpub/ckae204

Trama A, Bernasconi A, Cañete A, et al. Incidence and survival of rare adult solid cancers in Europe (EUROCARE-6): A population-based study. Eur J Cancer. 2025;214:115147. doi:10.1016/j.ejca.2024.115147

Vener C, Lillini R, De Angelis R, et al. Long-term survival for myeloid neoplasms and national health expenditure: A EUROCARE-6 retrospective, population-based study. Eur J Cancer. 2025;220:115231. doi:10.1016/j.ejca.2025.115231

Botta L, Didonè F, Lopez-Cortes A, et al. International benchmarking of stage at diagnosis for six childhood solid tumours (the BENCHISTA project): a population-based, retrospective cohort study. The Lancet Child & Adolescent Health. 2025;9(2):89-99. doi:10.1016/S2352-4642(24)00302-X

Di Carlo V, Eberle A, Stiller C, et al. Sex differences in survival from melanoma of the skin: The role of age, anatomic location and stage at diagnosis: A CONCORD-3 study in 59 countries. European Journal of Cancer. 2025;217:115213. doi:10.1016/j.ejca.2024.115213

Miyoshi J, Mannucci A, Scarpa M, et al. Liquid biopsy to identify Barrett’s oesophagus, dysplasia and oesophageal adenocarcinoma: the EMERALD multicentre study. Gut. 2025;74(2):169-181. doi:10.1136/gutjnl-2024-333364

Trama A, Lasalvia P, Stark D, et al. Incidence and survival of European adolescents and young adults diagnosed with sarcomas: EUROCARE-6 results. European Journal of Cancer. 2025;217:115212. doi:10.1016/j.ejca.2024.115212

Indini A, Didoné F, Massi D, et al. Corrigendum to “Incidence and prognosis of cutaneous melanoma in European adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results” [Eur J Cancer 213 (2024):115079]. European Journal of Cancer. 2025;218:115295. doi:10.1016/j.ejca.2025.115295

Gatta G, Calleja-Agius J, Sandrucci S, Azzopardi M, Capocaccia R, Hackl M. Incidence and survival of rare female genital tract cancers in Europe: The EUROCARE-6 study. Eur J Surg Oncol. Published online March 25, 2025:109996. doi:10.1016/j.ejso.2025.109996

Zhang M, Tierney P, Brennan A, Murray D, Mullooly M, Bennett K. Modelling the impact of the COVID-19 pandemic on cancer stage migration and excess mortality in Ireland. Prev Med Rep. 2025;52:103020. doi:10.1016/j.pmedr.2025.103020

Bernasconi A, Toss A, Zattarin E, et al. Prognosis of Breast Cancer in European female adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results. Breast. 2025;82:104472. doi:10.1016/j.breast.2025.104472

Ssenyonga N, Stiller CA, Marcos-Gragera R, et al. Conditional survival of children, adolescents and young adults (0-24 years) diagnosed with leukaemia during 2000-2014 world-wide: (CONCORD-3). Eur J Cancer. 2025;225:115445. doi:10.1016/j.ejca.2025.115445

Botta L, Capocaccia R, Vener C, et al. Estimating cure and risk of death from other causes of adolescent and young adult cancer patients in Europe. Eur J Cancer. 2025;222:115443. doi:10.1016/j.ejca.2025.115443

Trama A, Geerdes EE, Demuru E, et al. Survival of European children, adolescents and young adults diagnosed with haematological malignancies in the period 2000-2013: Results from EUROCARE-6, a population-based study. Eur J Cancer. 2025;222:115336. doi:10.1016/j.ejca.2025.115336